ExLibris header image
SFX Logo
Title: Anticancer Activity of Morphine and Its Synthetic Derivative, KT-90, Mediated through Apoptosis and Inhibition of NF-κB Activation
Source:

Biochemical and Biophysical Research Communications [0006-291X] Sueoka, Eisaburo yr:1998


Collapse list of basic services Basic
Full text
Full text available via EZB-NALI5-00465 Elsevier Archive NL
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Thun, Michael J J. "Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues." Journal of the National Cancer Institute 94.4: 252-266. Link to SFX for this item
2. Baron, John A A. "A randomized trial of aspirin to prevent colorectal adenomas." The New England journal of medicine 348.10 (2003): 891-9. Link to SFX for this item
3. Ulrich, Cornelia M M. "Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics." Nature reviews. Cancer 6.2 (2006): 130-40. Link to Full Text for this item Link to SFX for this item
4. Gupta, R A A. "Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2." Nature reviews. Cancer 1.1: 11-21. Link to SFX for this item
5. Levin, G. "The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis." The New England journal of medicine 342.26: 1946-1952. Link to SFX for this item
6. Kearney, P. "Do selective cyclo-oxygenase-2 inhibitors and traditional and non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials." BMJ 332.7553 (2006): 1302-1305. Link to SFX for this item
7. Sandler, Robert S S. "A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer." The New England journal of medicine 348.10 (2003): 883-890. Link to SFX for this item
8. Fang, Jing Yuan Y. "The MAPK signalling pathways and colorectal cancer." The lancet oncology 6.5 (2005): 322-7. Link to SFX for this item
9. Harris, H. "A long view of fashions in cancer research." BioEssays 27.8 (2005): 833-838. Link to Full Text for this item Link to SFX for this item
10. Huls, G. "Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas." The lancet 362.9379 (2003): 230-2. Link to SFX for this item
11. DuBois, R N N. "The role of cyclooxygenases in inflammation, cancer, and development." Oncogene 18.55: 7908-7916. Link to SFX for this item
12. Schuman, T R M. "The effect of fecal occult-blood screening on the incidence of colorectal cancer." New England Journal of Medicine, The 343.22 (2000): 1603-7. Link to SFX for this item
13. Bertagnolli, Monica M M. "Celecoxib for the Prevention of Sporadic Colorectal Adenomas." The New England journal of medicine 355.9: 873-884. Link to SFX for this item
14. Weinberg, R A A. "How cancer arises." Scientific American 275.3 (1996): 62-70. Link to SFX for this item
15. Hanahan, D. "The hallmarks of cancer." Cell 100.1 (1999): 57-70. Link to SFX for this item
16. Gillen, G. "Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial." Cancer prevention research 1.1 (2008): 9-11. Link to SFX for this item
17. Cramer, D W W. "Genital talc exposure and risk of ovarian cancer." International journal of cancer 81.3 (1999): 351-6. Link to Full Text for this item Link to SFX for this item
18. van de Waterbeemd, H. "ADMET in silico modelling: towards prediction paradise?" Nature reviews. Drug discovery 2.3 (2003): 192-204. Link to Full Text for this item Link to SFX for this item
19. Wolfe, M M M. "Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs." New England Journal of Medicine, The 340.24 (1999): 1888-1899. Link to SFX for this item
20. Hynes, Nancy E E. "ERBB receptors and cancer: the complexity of targeted inhibitors." Nature reviews. Cancer 5.5 (2005): 341-54. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced